Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-24-086021
Filing Date
2024-10-07
Accepted
2024-10-07 19:36:12
Documents
1
Group Members
DOVET LTDROWLAND MASTER TRUSTSTOCKTON LTD

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G ea0216964-13ga2nirland_con.htm SC 13G/A 130686
  Complete submission text file 0001213900-24-086021.txt   132472
Mailing Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123
Business Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123 (760) 471 8536
CONDUIT PHARMACEUTICALS INC. (Subject) CIK: 0001896212 (see all company filings)

IRS No.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93313 | Film No.: 241358932
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address THE OLD STABLES RUE LOR ST PETER PORT Y7 GY1 1QG
Business Address THE OLD STABLES RUE LOR ST PETER PORT Y7 GY1 1QG 44 1481 233076
Nirland Ltd (Filed by) CIK: 0001994188 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Y7 | Fiscal Year End: 1231
Type: SC 13G/A